NANCY COTE: Open Payments
NPI 1568401735 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 62 payments from 14 companies in 2025. Trend: 2023 $185 · 2024 $1,548 · 2025 $1,109
Food & beverage: $949Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $263 |
| ABBVIE INC. | 16 | $230 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $210 |
| Arcutis Biotherapeutics, Inc. | 13 | $146 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| UCB, Inc. | 2 | $37 |
| Incyte Corporation | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| PFIZER INC. | 1 | $27 |
| Amgen Inc. | 1 | $25 |
Products named: TREMFYA, Zoryve, SKYRIZI, ILUMYA, RINVOQ, COSENTYX, Bimzelx, OPZELURA.
Industry payments across CA — which companies pay providers there.
